跳至主要内容
临床试验/PACTR201505001107182
PACTR201505001107182已完成未知

COMPARATIVE EFFECTIVENESS OF 200µG VERSUS 400µG OF SUBLINGUAL MISOPROSTOL FOR THE PREVENTION OF PRIMARY POSTPARTUM HAEMORRHAGE: A RANDOMISED CONTROLLED TRIA

Dr I.A Ugwu0 个研究点目标入组 0 人开始时间: 2015年4月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 45 Year(s)(—)
性别
Female

入选标准

  • Women at term with singleton pregnancy in active phase labour, or
  • women undergoing induction of labour and with anticipated spontaneous vaginal delivery

排除标准

  • contraindications for use of misoprostol such as asthma
  • paturients undergoing caesarean section
  • presence of coagulation disorders
  • pre-eclampsia and other hypertensive diseases in pregnancy
  • conditions requiring prophylactic oxytocin infusion after delivery such as grandmultiparity, multiple pregnancy, polyhydramnios and coexisiting uterine fibroids
  • previous history of postpartum haemorrhage
  • history of anteparturm haemorrhage
  • Refusal or withdrawal of consent

研究者

发起方
Dr I.A Ugwu

相似试验